Moneycontrol
HomeNewsBusinessAt 93 lakh in FY21, every 1 in 3 health insurance policies is sold to a woman in India

At 93 lakh in FY21, every 1 in 3 health insurance policies is sold to a woman in India

Every one in three life insurance policies in India is sold to a woman. The number of policies issued to women in FY21 stood at 93 lakh during the year.

March 22, 2022 / 12:15 IST
Story continues below Advertisement
Representative image

While health insurance retailing recorded a 28.5 percent surge in sales after the pandemic shock, one in every three policies were sold to a woman, shows a study conducted by the State Bank of India.

Let's take a look at some some major trends in the insurance industry emerged during the pandemic and in the post-COVID India.

Story continues below Advertisement

Also Read: Want to increase your health insurance cover at low cost? Buy a top-up or super top-up policy

Also Read: Transgender health insurance to get a boost; clear underwriting philosophy needed, regulator says

In its report, SBI suggests that in order to plug the protection gap quickly, in line with Jan Suraksha, the government should come out with some standardised products for various sectors so that the protection gap in each segment can be reduced significantly.

For example, by considering 2020 floods in India, the total economic loss was Rs 52,500 crore, but insurance was of only 11 percent. If the government would have insured it, then the premium for the sum assurance of Rs 60,000 crore would have been only in the range of Rs 13,000 to Rs 15,000 crore - saving the government of at least Rs 40,000 crore.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show
Moneycontrol News
first published: Mar 22, 2022 12:41 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!